Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

FORGOTTEN HISTORY: What are wall street analysts target price for merck stock - Caught on Camera

Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, the company delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. 

Shares of this pharmaceutical giant have considerably underperformed the broader market over the past year. MRK has declined 21.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.9%. In 2025, MRK stock is up marginally, compared to the SPX’s 1.9% rise on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.